Swiss National Bank Vbi Vaccines Inc Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.66 - $1.81 $20,064 - $55,024	30,400 Added 7.14%	456,200 $369,000
Q1 2022 May 09, 2022	BUY	$1.27 - $2.47 $41,529 - $80,769	32,700 Added 8.32%	425,800 $707,000
Q3 2021 Nov 08, 2021	BUY	$2.8 - $3.72 $54,880 - $72,912	19,600 Added 5.25%	393,100 $1.22 Million
Q2 2021 Aug 06, 2021	SELL	$2.61 - $4.17 $35,757 - $57,129	-13,700 Reduced 3.54%	373,500 $1.25 Million
Q1 2021 May 07, 2021	BUY	$2.91 - $4.32 $61,983 - $92,016	21,300 Added 5.82%	387,200 $1.2 Million
Q4 2020 Feb 05, 2021	BUY	$2.15 - $3.5 $786,685 - $1.28 Million	365,900 New	365,900 $1.01 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.